NeuroPace, Inc. () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1282993,
    "name": "NeuroPace, Inc.",
    "stock_name": "NeuroPace, Inc.",
    "full_name": "NeuroPace, Inc.",
    "name_url": "stocks-analysis/neuropace-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "16.97",
    "chg": 0.95,
    "chgp": "5.93%",
    "dir": 1,
    "prev_price": "16.02",
    "mcapval": "321.22",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2325,
    "indexname": "S&P 500",
    "isin": "US6412881053",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "446.27 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/neuropace-inc-1282993-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is NeuroPace, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-neuropace-inc-technically-bullish-or-bearish-3546563",
        "imagepath": "",
        "date": "2025-09-20 19:35:47",
        "description": "As of 3 September 2025, the technical trend for NeuroPace, Inc. has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the monthly MACD shows a mildly bearish outlook. The moving averages are mildly bearish on a daily basis, and the Bollinger Bands are also mildly bearish on both weekly and monthly time frames. The KST presents a mixed view with a bearish weekly signal and a bullish monthly signal. Dow Theory reflects a mildly bullish weekly stance but is mildly bearish monthly. The OBV is mildly bullish weekly and mildly bearish monthly.\n\nIn terms of performance, NeuroPace has outperformed the S&P 500 over the past week and month, with returns of 3.1% and 22.57% respectively, compared to the S&P 500's 1.05% and 2.33%. However, it has underperformed year-to-date with a return of -7.77% against the S&P 500's 12.22%. Overall, the current technical stance is mildly..."
      },
      {
        "title": "Is NeuroPace, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-neuropace-inc-overvalued-or-undervalued-3543111",
        "imagepath": "",
        "date": "2025-09-20 18:10:53",
        "description": "As of 3 June 2021, the valuation grade for NeuroPace, Inc. moved from does not qualify to risky. The company appears to be overvalued based on its financial metrics. Key ratios include a Price to Book Value of 17.77, an EV to EBIT of -22.14, and an EV to Sales of 5.06, which suggest that the company is not generating sufficient earnings relative to its valuation.\n\nIn comparison to its peers, NeuroPace, Inc. has a P/E ratio of -12.59, while ZimVie, Inc. has a significantly higher P/E of -80.95, and AngioDynamics, Inc. stands at -24.69. These ratios indicate that NeuroPace is underperforming relative to its peers. Notably, the stock has outperformed the S&P 500 over the past year with a return of 51.32% compared to the S&P 500's 17.14%, but this does not negate the overall valuation concerns...."
      }
    ],
    "total": 6,
    "sid": "1282993",
    "stock_news_url": "https://www.marketsmojo.com/news/neuropace-inc-1282993"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is NeuroPace, Inc. technically bullish or bearish?

2025-09-20 19:35:47

As of 3 September 2025, the technical trend for NeuroPace, Inc. has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the monthly MACD shows a mildly bearish outlook. The moving averages are mildly bearish on a daily basis, and the Bollinger Bands are also mildly bearish on both weekly and monthly time frames. The KST presents a mixed view with a bearish weekly signal and a bullish monthly signal. Dow Theory reflects a mildly bullish weekly stance but is mildly bearish monthly. The OBV is mildly bullish weekly and mildly bearish monthly. In terms of performance, NeuroPace has outperformed the S&P 500 over the past week and month, with returns of 3.1% and 22.57% respectively, compared to the S&P 500's 1.05% and 2.33%. However, it has underperformed year-to-date with a return of -7.77% against the S&P 500's 12.22%. Overall, the current technical stance is mildly...

Is NeuroPace, Inc. overvalued or undervalued?

2025-09-20 18:10:53

As of 3 June 2021, the valuation grade for NeuroPace, Inc. moved from does not qualify to risky. The company appears to be overvalued based on its financial metrics. Key ratios include a Price to Book Value of 17.77, an EV to EBIT of -22.14, and an EV to Sales of 5.06, which suggest that the company is not generating sufficient earnings relative to its valuation. In comparison to its peers, NeuroPace, Inc. has a P/E ratio of -12.59, while ZimVie, Inc. has a significantly higher P/E of -80.95, and AngioDynamics, Inc. stands at -24.69. These ratios indicate that NeuroPace is underperforming relative to its peers. Notably, the stock has outperformed the S&P 500 over the past year with a return of 51.32% compared to the S&P 500's 17.14%, but this does not negate the overall valuation concerns....

View All News